S-3ASR ·Filed Aug 6, 2026

GILD

GILEAD SCIENCES, INC.
NEUTRAL
Impact 2/10
Horizonmonths Processed1mo ago SEC0001104659-26-092110
Notable filing: S-3ASR
Actionable Insight • Neutral

This is a routine shelf filing with no immediate trading implications. Monitor for future prospectus supplements that would indicate an actual offering, which could signal a change in capital allocation strategy or a need for funding.

DirectionNeutral
Confidencehigh
Horizonmonths
Latest settled — T+20d
GILD ▲ +13.35% at T+20d
NEUTRAL call ✓ call won +13.35% · α vs SPY +13.75% · entry $133.21 → $151.00
Next anchor: T+60d in 28d
Latest observation: T+38 +17.69% FF3 residual α
Entry anchored
Aug 6, 05:04 PM ET
via 1-min bar
T+1d
-0.11%
call -0.11% · α -0.08%
$133.06
settled 8w ago
T+5d
+3.87%
call +3.87% · α +3.47%
$138.36
settled 7w ago
T+20d
+13.35%
call +13.35% · α +13.75%
$151.00
settled 29d ago
T+60d
—
call — · α —
—
in 28d

Price Chart

Loading chart...

Executive Summary

Gilead Sciences filed an automatic shelf registration statement (S-3ASR) on August 6, 2026, registering an indeterminate amount of debt securities, common stock, preferred stock, depositary shares, warrants, subscription rights, stock purchase contracts, and stock purchase units for potential future sale. The filing is a routine administrative step for a large, well-capitalized company, enabling it to access capital markets quickly when needed. No specific offering is being made at this time, and the registration fees are deferred under a pay-as-you-go basis.

Key Facts

  • Gilead filed an S-3ASR on August 6, 2026, registering an indeterminate amount of various securities for potential future sale.
  • The filing is a universal shelf registration, allowing Gilead to offer and sell securities from time to time on a delayed or continuous basis.
  • Registration fees are deferred under Rules 456(b) and 457(r), meaning no immediate offering is being made.
  • The company has a market cap of $163.6B and has filed 5 offering/registration documents in the last 24 months, indicating routine capital management.
  • Net proceeds from any future sale would be used for general corporate purposes.

Financial Impact

No offering size or pricing is disclosed; this is a shelf registration with an indeterminate amount. The filing itself has no immediate financial impact.

Risk Factors

  • Future offerings under this shelf could dilute existing shareholders if common stock is issued.
  • The filing itself does not indicate any immediate capital need or distress.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
81% bullish (37 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
S-3ASR Filing (Primary)0001104659-26-092110
Document: tm2621295d2_ex25-1.htm0001104659-26-092110
Document: tm2621295d1_ex-filingfees.htm0001104659-26-092110
Document: tm2621295d2_ex5-1.htm0001104659-26-092110
Document: tm2621295d2_ex23-1.htm0001104659-26-092110
Document: 0001104659-26-092110-index-headers.html0001104659-26-092110
Document: 0001104659-26-092110-index.html0001104659-26-092110
Document: 0001104659-26-092110.txt0001104659-26-092110
16 reports for GILD
Performance horizon
83% Hit rate 5 of 6 directional calls best @ T+60▲ +16.72%Jul 6, 2026
Filters
Rows
Reports for GILD — sortable, filterable
TypeNow
Sep 2, 2026
4w ago
Insider Cluster
NEUTRAL ★ 2/10
$149.61 $149.05▼ −0.37%▼ −0.04%$144.74 (−3.26%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$145.68 $152.21▲ +4.48%▲ +4.22%$144.74 (−0.65%)
Aug 21, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$146.74 $152.67▲ +4.04%▲ +2.73%$144.74 (−1.36%)
Aug 18, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$147.60 $150.89▲ +2.23%▲ +4.18%$144.74 (−1.94%)
Aug 18, 2026
6w ago
Court Ruling
BULLISH ★ 7/10
$143.44 $147.68▲ +2.96%▲ +4.27%$144.74 (+0.91%)
Aug 13, 2026
7w ago
Court Ruling
BULLISH ★ 6/10
$138.14 $143.72▲ +4.04%▲ +5.79%$144.74 (+4.78%)
Aug 6, 2026
8w ago
S-3ASR
NEUTRAL ★ 2/10
$133.21 $151.00▲ +13.35%▲ +13.75%$144.74 (+8.66%)
Jul 21, 2026
10w ago
ANALYST-DOWNGRADE
BEARISH ★ 4/10
$130.28 $143.44▼ −10.10%▼ −7.54%$144.74 (−11.10%)
Jul 16, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$134.28 $138.33▲ +3.02%▼ −1.43%$144.74 (+7.79%)
Jul 6, 2026
12w ago
ANALYST-UPGRADE
BULLISH ★ 3/10
$129.61 $130.21▲ +0.46%▲ +1.03%$144.74 (+11.67%)
Showing 10 of 16

US Market Status

Market Closed — Opens Mon (65h 7m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access